Literature DB >> 33706582

Redox treatment ameliorates diabetes mellitus-induced skin flap necrosis via inhibiting apoptosis and promoting neoangiogenesis.

Yeon S Kim1, Hye-Young Lee2, Jeon Y Jang2, Hye R Lee2, Yoo S Shin2, Chul-Ho Kim2.   

Abstract

Intractable wound healing is the habitual problem of diabetes mellitus. High blood glucose limits wound healing by interrupting inflammatory responses and inhibiting neoangiogenesis. Oxidative stress is commonly thought to be a major pathogenic cause of diabetic complications. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one, EDV) is a free radical scavenger which suppress oxidative stress. This study investigates whether EDV can reduce oxidative stress in wound healing HaCaT/human dermal fibroblasts cells (HDFs) in vitro and in vivo animal model. Cell viability and wound healing assays, FACS flow cytometry, and Hoechst 33342 staining were performed to confirm apoptosis and cytotoxicity in H2O2 and EDV-treated HaCaT and HDFs. A streptozotocin-induced hyperglycemic animal model was made in adult C57BL6 mice. Full-thickness skin flap was made on dorsomedial back and re-sutured to evaluate the wound healing process. EDV was delivered slowly in the skin flap with degradable fibrin glue. The flap was monitored and analyzed on postoperative days 1, 3, and 5. CD31/DAPI staining was done to detect newly formed blood vessels. The expression levels of NF-κB, bcl-2, NOX3, and STAT3 proteins in C57BL6 mouse tissues were also examined. The wound healing process in hyper- and normoglycemic mice showed a difference in protein expression, especially in oxidative stress management and angiogenesis. Exogenous H2O2 reduced cell viability in a proportion to the concentration via apoptosis. EDV protected HaCaT cells and HDFs from H2O2 induced reactive oxygen species cell damage and apoptosis. In the mouse model, EDV with fibrin resulted in less necrotic areas and increased angiogenesis on postoperative day 5, compared to sham-treated mice. Our results indicate that EDV could protect H2O2-induced cellular injury via inhibiting early apoptosis and inflammation and also increasing angiogenesis. EDV might be valuable in the treatment of diabetic wounds that oxidative stress has been implicated.

Entities:  

Keywords:  Chronic wounds; diabetes mellitus; edaravone; oxidative stress; reactive oxygen species

Mesh:

Substances:

Year:  2020        PMID: 33706582      PMCID: PMC7988729          DOI: 10.1177/1535370220974269

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  56 in total

1.  Delivery of non-viral gene carriers from sphere-templated fibrin scaffolds for sustained transgene expression.

Authors:  Justin M Saul; Michael P Linnes; Buddy D Ratner; Cecilia M Giachelli; Suzie H Pun
Journal:  Biomaterials       Date:  2007-08-06       Impact factor: 12.479

2.  In vitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels.

Authors:  T L Tuan; A Song; S Chang; S Younai; M E Nimni
Journal:  Exp Cell Res       Date:  1996-02-25       Impact factor: 3.905

3.  Clinical Effects of Early Edaravone Use in Acute Ischemic Stroke Patients Treated by Endovascular Reperfusion Therapy.

Authors:  Masaya Enomoto; Akira Endo; Hiroshi Yatsushige; Kiyohide Fushimi; Yasuhiro Otomo
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

Review 4.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition.

Authors:  Britta Kunkemoeller; Themis R Kyriakides
Journal:  Antioxid Redox Signal       Date:  2017-08-10       Impact factor: 8.401

5.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

Review 6.  Reactive oxygen species and bacterial biofilms in diabetic wound healing.

Authors:  Aksone Nouvong; Aaron M Ambrus; Ellen R Zhang; Lucas Hultman; Hilary A Coller
Journal:  Physiol Genomics       Date:  2016-10-07       Impact factor: 3.107

Review 7.  Insulin Promotes Wound Healing by Inactivating NFkβP50/P65 and Activating Protein and Lipid Biosynthesis and alternating Pro/Anti-inflammatory Cytokines Dynamics.

Authors:  Pawandeep Kaur; Diptiman Choudhury
Journal:  Biomol Concepts       Date:  2019-02-22

8.  Peroxynitrite versus nitric oxide in early diabetes.

Authors:  Robert D Hoeldtke; Kimberly D Bryner; Daniel R McNeill; Gerald R Hobbs; Chris Baylis
Journal:  Am J Hypertens       Date:  2003-09       Impact factor: 2.689

9.  High glucose-mediated oxidative stress impairs cell migration.

Authors:  Marcelo L Lamers; Maíra E S Almeida; Miguel Vicente-Manzanares; Alan F Horwitz; Marinilce F Santos
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  Effect of edaravone in diabetes mellitus-induced nephropathy in rats.

Authors:  Rajavel Varatharajan; Li Xin Lim; Kelly Tan; Chai Sze Tay; Yi Leng Teoh; Shaikh Sohrab Akhtar; Mani Rupeshkumar; Ivy Chung; Nor Azizan Abdullah; Urmila Banik; Sokkalingam A Dhanaraj; Pitchai Balakumar
Journal:  Korean J Physiol Pharmacol       Date:  2016-06-23       Impact factor: 2.016

View more
  2 in total

1.  Melatonin Improved the Survival of Multi-Territory Perforator Flaps by Promoting Angiogenesis and Inhibiting Apoptosis via the NRF2/FUNDC1 Axis.

Authors:  Chengxiong Huang; Liming Qing; Xiaoyang Pang; Jinfei Fu; Yu Xiao; Juyu Tang; Panfeng Wu
Journal:  Front Pharmacol       Date:  2022-05-24       Impact factor: 5.988

2.  Edaravone Attenuated Particulate Matter-Induced Lung Inflammation by Inhibiting ROS-NF-κB Signaling Pathway.

Authors:  Yingying Zeng; Guiping Zhu; Mengchan Zhu; Juan Song; Hui Cai; Yuanlin Song; Jian Wang; Meiling Jin
Journal:  Oxid Med Cell Longev       Date:  2022-04-23       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.